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Abstract 
Background: Scale‑up of malaria interventions seems to have contributed to a decline in the disease but other fac‑
tors may also have had some role. Understanding changes in transmission and determinant factors will help to adapt 
control strategies accordingly.
Methods: Four sites in Ethiopia and Uganda were set up to monitor epidemiological changes and effectiveness of 
interventions over time. Here, results of a survey during the peak transmission season of 2012 are reported, which will 
be used as baseline for subsequent surveys and may support adaptation of control strategies. Data on malariometric 
and entomological variables, socio‑economic status (SES) and control coverage were collected.
Results: Malaria prevalence varied from 1.4 % in Guba (Ethiopia) to 9.9 % in Butemba (Uganda). The most domi‑
nant species was Plasmodium vivax in Ethiopia and Plasmodium falciparum in Uganda. The majority of human‑vector 
contact occurred indoors in Uganda, ranging from 83 % (Anopheles funestus sensu lato) to 93 % (Anopheles gambiae 
s.l.), which is an important factor for the effectiveness of insecticide‑treated nets (ITNs) or indoor residual spraying 
(IRS). High kdr‑L1014S (resistance genotype) frequency was observed in A. gambiae sensu stricto in Uganda. Too few 
mosquitoes were collected in Ethiopia, so it was not possible to assess vector habits and insecticide resistance levels. 
ITN ownership did not vary by SES and 56–98 % and 68–78 % of households owned at least one ITN in Ethiopia and 
Uganda, respectively. In Uganda, 7 % of nets were purchased by households, but the nets were untreated. In three 
of the four sites, 69–76 % of people with access to ITNs used them. IRS coverage ranged from 84 to 96 % in the three 
sprayed sites. Half of febrile children in Uganda and three‑quarters in Ethiopia for whom treatment was sought 
received diagnostic tests. High levels of child undernutrition were detected in both countries carrying important 
implications on child development. In Uganda, 7–8 % of pregnant women took the recommended minimum three 
doses of intermittent preventive treatment.
Conclusion: Malaria epidemiology seems to be changing compared to earlier published data, and it is essential to 
have more data to understand how much of the changes are attributable to interventions and other factors. Regular 
monitoring will help to better interpret changes, identify determinants, modify strategies and improve targeting to 
address transmission heterogeneity.
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provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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Background
The malaria burden has declined worldwide in the past 
decade. Malaria mortality rates decreased by 47 % glob-
ally and by 54  % in the WHO African Region between 
2000 and 2013 [1]. During the same period, prevalence 
of infection in children aged 2–10 years decreased from 
26 to 14 %—a 48 % decline [1]. Factors that are believed 
to have had a significant on this trend impact include the 
scale-up of key vector control interventions, availability 
of rapid diagnostic tests (RDTs) and effective treatment 
with artemisinin-based combination therapy (ACT) [2, 
3]. However, the trend has not been uniform. In some 
areas with high baseline transmission and/or where high 
coverage levels have not been achieved, the malaria bur-
den has not declined [4–7].
The changing epidemiology of malaria requires adap-
tation of interventions to address shifts in geographi-
cal, behavioural and demographic risk characteristics, 
especially as transmission declines and becomes more 
clustered [8]. A deeper understanding of possible deter-
minants of change is critically important. Local knowl-
edge of the burden and features of the disease will be 
important to adapt interventions and maintain cost-effec-
tiveness and equity. Features that need to be monitored 
include: changes in vector habits and insecticide resist-
ance, parasite infection patterns and drug resistance, cli-
matic, socio-economic and demographic changes, gaps 
or issues in implemented interventions, and effectiveness 
and relevance of some control strategies.
Furthermore, a good surveillance system is essential 
to identify most at-risk populations and geographical 
areas and to assess trends and impact of interventions 
[9]. In addition to surveillance and monitoring of empiri-
cal data, appropriate mathematical models are useful to 
understand the malaria transmission dynamics. Examin-
ing various scenarios, including the extent to which a set 
of interventions can reduce malaria to low levels, could 
help to use resources optimally.
Detailed epidemiological studies have been carried out 
with the aim of understanding the likelihood of inter-
ruption of malaria transmission in Africa. One of the 
best examples of such studies was the epidemiological 
research undertaken in the Garki Project during 1969–
1976 in a lowland rural Sudan savanna in northern Nige-
ria [10]. The goal was to test the effects of indoor residual 
spraying (IRS) and mass drug administration and to 
develop and test a mathematical model of transmission. 
Although potent interventions were applied, interruption 
of transmission was not achieved. Part of this failure was 
attributed to non-uniform exposure to sprayed surfaces 
due to at least partial genetically determined outdoor 
resting populations of Anopheles gambiae s.l. However, 
the model constructed by the project proved useful for 
planning malaria control interventions. More recently, 
a malaria model was developed, which has been pro-
posed to be used in elimination scenario planning [11, 
12]. Models could be used to extrapolate realistic pre-
dictions in larger geographical areas for selective control 
planning and evaluation of effectiveness of interventions 
in bringing down transmission to a low level. Data from 
the present project could be used to validate such models 
and to stratify areas for optimum impact within available 
resources. The project which is the subject of this paper 
was named ‘Beyond Garki’ to recognize the contribution 
of the Garki Project to the understanding of malaria epi-
demiology in Africa.
The project is led by Malaria Consortium and imple-
mented in collaboration with the Ethiopian Public 
Health Institute and Ministries of Health in Ethiopia and 
Uganda, alongside Regional/District Health Offices in the 
study sites. Here, the project is described and data on sev-
eral variables presented, including malaria epidemiology, 
vector behaviour and insecticide resistance, demographic 
and socio-economic factors, treatment-seeking behav-
iour and coverage of interventions in the study sites from 
a baseline survey carried out in October and November 
of 2012. Three more rounds of surveys have been carried 
out up to November 2014. The detailed results of these 
surveys and other data in comparison with the baseline 
survey will be published elsewhere.
Methods
Study sites
A ‘study site’ in the context of the project is defined as a 
‘health centre and the catchment population in selected 
villages around it’. Two study sites were selected per 
country in Ethiopia and Uganda, representing different 
epidemiological settings in rural environments (Table 1).
The selection of the study sites was based on the need 
to represent different epidemiological (transmission) set-
tings, geographical location and accessibility, and avail-
ability of adequate baseline morbidity data. The four 
study sites represented settings ranging from low sea-
sonal transmission in the Ethiopia sites to high perennial 
transmission in the Uganda sites. Only villages in close 
proximity to the health centres were selected, covering a 
Keywords: Malaria, Plasmodium falciparum, Plasmodium vivax, Anopheles gambiae, Anopheles arabiensis, Anopheles 
funestus, Vector control, Epidemiology, Undernutrition
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radius of approximately 2–6 kms to reduce potential bias 
in the analysis of treatment-seeking and use of services 
by the study population.
Ethiopia
Most areas below 2000 m above sea level are considered 
malarious in Ethiopia. An estimated 60  % of the popu-
lation live in areas at risk of malaria transmission [13]. 
Both Plasmodium falciparum and Plasmodium vivax 
are common. The Malaria Indicator Survey (MIS) dur-
ing October-December 2011 showed that nationally the 
prevalence of malaria was 1.3 % in areas below 2000 m; 
77  % of the positive slides were P. falciparum infec-
tions [14]. There is marked seasonality in transmission 
and geographic variation in intensity. Many areas are 
epidemic-prone. Anopheles arabiensis is the main vec-
tor species [15]. Anopheles pharoensis, Anopheles funes-
tus and Anopheles nili are considered secondary vectors. 
Resistance of the main vector against DDT and pyre-
throids is widespread in the country [16].
Ethiopia’s organized malaria control began in 1959 
when the Malaria Eradication Service was established a 
year after a major epidemic claimed an estimated 150,000 
lives [17]. A blanket DDT spraying campaign was used 
until the early 1970s, when the eradication strategy was 
abandoned and replaced with a control programme 
[18]. The programme, based on selective spraying and 
treatment of cases, continued until the mid-1990s after 
which the specialized service was gradually integrated 
into the general health services. There has been a sub-
stantial increase in coverage of key interventions in the 
country. More than 64 million long-lasting insecticidal 
nets (LLINs) were distributed through mass campaigns 
between 2005 and 2014 [13]. IRS is also implemented in 
many areas. Through the expansion of basic health ser-
vices, mainly health posts, diagnostic and treatment ser-
vices have increased over the years.
Uganda
Malaria is highly endemic in approximately 95  % of the 
country where 90  % of the population live. The MIS in 
November and December 2009 reported that 42  % of 
children under the age of five tested positive for malaria 
with microscopic diagnosis [19]. Plasmodium falcipa-
rum is responsible for 99 % of malaria cases. The disease 
accounts for 25–40 % outpatient visits and nearly half of 
inpatient paediatric deaths [20]. The main malaria vec-
tors are Anopheles gambiae s.s., A. arabiensis and A. 
funestus [19, 20].
Although IRS was implemented in limited sites as part 
of the WHO pilot programme between 1959 and 1963, 
the operation was not scaled up [21]. Treatment of cases 
remained the only malaria control measure for many 
years. The Malaria Control Unit was established in 1995 
and grew into the National Malaria Control Programme. 
The main preventive interventions in Uganda are LLINs, 
IRS in selected districts, and intermittent preventive 
treatment in pregnancy (IPTp). Uganda has scaled up 
effective case management and in some regions vil-
lage health teams (VHTs) were trained to test and treat 
common childhood illnesses including malaria through 
Integrated Community Case Management (ICCM). In 
2009, 47 % of households owned at least one insecticide-
treated net (ITN) compared to 16 % in 2006 [19, 22]; this 
increased to 60  % in 2011 [23]. These combined efforts 
are believed to have resulted in reduced transmission in 
many areas [24].
Up to 10 districts in northern Uganda have been 
sprayed in the past 6–7 years within the IRS programme 
supported by the US Government’s Presidential Malaria 
Initiative (PMI) [20]. Starting from 2014, more north-
ern and eastern districts were added while the operation 
ended in others (including Apac, the district containing 
the study site Aduku) due to a decline in transmission. 
A large reduction in malaria prevalence was observed in 
children living in sprayed areas compared to those living 
in unsprayed areas [25]. Meanwhile, more than 21 mil-
lion LLINs were distributed in a nation-wide mass cam-
paign during 2012–2014.
Study components
Repeat cross-sectional surveys were conducted in the 
selected sites (of which only results from the first study 
are presented here as the baseline data). The study also 
Table 1 Beyond Garki study sites in Uganda and Ethiopia
SNNP Southern Nations, Nationalities and Peoples
Country Region District Study site Coordinates of health centre:  
latitude, longitude
Average altitude 
of study site (m)
Uganda Northern Region Apac Aduku 1°59′33.51″N, 32°43′8.26″E 1051
Central Region Kyankwanzi Butemba 1°8′33.86″N, 31°36′8.79″E 1107
Ethiopia SNNP Region Boloso Sore Hembecho 7°8′59.08″N, 37°39′42.05″E 1702
SNNP Region Halaba Special Guba 7o17′6.88″N, 38o13′1.09″E 1878
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included longitudinal collection of meteorological and 
morbidity data at health facilities. The main components 
include: household surveys, malariometric and serologi-
cal surveys, entomological surveys, health facility-based 
morbidity studies, and climatic studies. For the house-
hold surveys, the required sample size was estimated 
for each site by assuming 5 and 50  % baseline preva-
lence in children below 10 years in Ethiopia and Uganda, 
respectively.
Household surveys
All households in villages around each health cen-
tre (within radius of 2–6  kms) were enumerated and 
included in the sampling frame. A simple random sample 
of 571 and 234 households were selected in each site in 
Ethiopia and Uganda, respectively. The sample sizes were 
determined separately for the two countries based on 
expected malaria prevalence rates, household sizes and a 
10 % non-response rate using appropriate statistical pro-
cedures, and sample sizes for each site were calculated 
independently assuming simple random sampling. The 
household surveys included interviews with household 
heads and women aged 15–49  years of age using hand-
held devices (smartphones with Pendragon Forms 5.1 or 
tablets with Open Data Kit). Data were collected on vari-
ables indicating socio-economic status (SES), prevention 
methods, knowledge about malaria, ITN ownership and 
use, as well as number of children born to interviewed 
women who were alive and dead, febrile illness in chil-
dren, treatment sought and protection against malaria 
during pregnancy.
Malariometric surveys
Each member of the sampled households (except infants 
under 6  months) was given a subject card and asked to 
visit a malariometric testing site within the village to 
obtain anthropometric measurements and collect blood 
samples. Bodyweight, temperature, height and mid-
upper arm circumference were measured for children 
under five. Thick and thin blood films for microscopy, dry 
blood spots for serology and blood samples for haemo-
globin measurement using the HemoCue machine (Hb 
301, Ängelholm, Sweden) were obtained for all subjects. 
RDTs (CareStart™ pf-HRP2/pan-pLDH by Access Bio 
USA in Ethiopia and SD Bioline in Uganda) were used to 
test subjects with body temperature 37.5  °C and above 
or history of fever in the previous 48 h. Individuals with 
fever or history of fever were tested by RDT for the pur-
pose of providing anti-malarial treatment. Treatment was 
provided at the field site according to national guidelines 
for mild and moderate anaemia (using ferrous sulphate) 
and uncomplicated malaria cases (using artemether–
lumefantrine for P. falciparum and chloroquine for P. 
vivax), while severe cases were referred to the site’s 
health centre.
Slides were stained with Giemsa and examined by two 
independent microscopists for presence/absence of asex-
ual parasites and gametocytes and species identification. 
In the case of discrepant results, a third microscopist 
examined the slides for a final verification.
Serological analysis of dry blood spots from the 
Uganda sites was carried out to determine antibody 
responses to assess malaria transmission intensity over 
an extended period of time. The antibody response of 
individuals against merozoite surface protein-119 (MSP-
119) was determined using an enzyme-linked immuno-
sorbent assay (ELISA). Serum obtained from the dried 
blood spots on filter papers was analysed at the Medi-
cal Research Council (MRC) Laboratory in Uganda for 
total IgG antibodies using P. falciparum antigen MSP-119 
(CTK Biotech, USA, cat. No. A3003) following previously 
described methods [26, 27].
Entomological surveys
Anopheles mosquitoes were sampled to determine spe-
cies composition, densities, behaviour and insecticide 
resistance using light trap collection, exit trap collec-
tion, room search, pyrethrum spray catch and human 
landing catch (HLC) in 12 houses per site selected using 
simple random sampling from the sampling frame for 
the household survey. Mosquitoes were identified using 
morphological features and individually packed in micro-
tubes for molecular analysis, which were carried out at 
Rothamsted Research in the UK [28]. Genomic DNA was 
extracted using the Livak method. A. gambiae s.l. sam-
ples were analysed to determine whether they were A. 
gambiae s.s. or A. arabiensis [29, 30]. Anopheles gambiae 
s.l. samples were analysed mainly for knock down resist-
ance (kdr) mutations (but also for mutation in the ace-
1 gene which encodes the acetylcholinesterase enzyme 
although not reported here) [31].
Other study components
Other components of the study not reported in the pre-
sent paper include: use of automatic weather stations 
(BWS200 automatic weather station, Campbell Scientific, 
Stellenbosch, South Africa) installed in all sites to record 
hourly meteorological data, compilation of outpatient 
morbidity data for every suspected or confirmed malaria 
patient seen at the health facility in each site, and math-
ematical modelling of transmission.
Ethical considerations
Ethical clearance was obtained from the appropri-
ate review boards (Uganda: UNCST 1348; Ethiopia: 
3-10/819/05). In addition, written consent was obtained 
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from respondents for interviews, for all subjects that par-
ticipated in malariometric surveys, and from household 
heads for entomology sentinel houses.
Data entry and analysis
EpiData v3.1 (The EpiData Association, Odense, Den-
mark) was used for data entry where necessary. Stata ver-
sions 12 and 13 (StataCorp LP, College Station, TX, USA) 
and Microsoft Excel (Microsoft Corporation) were used 
for data analysis.
Household survey data
Chi squared tests were used where appropriate to assess 
significant differences between groups of interest, tak-
ing into account clustering at household level. Principal 
components analysis (PCA) was used to calculate wealth 
index for each household, computed separately for each 
country.
Malaria infection rates
Infection prevalence data were analysed in relation to 
potential household or individual risk factors such as 
coverage and use of prevention methods, housing condi-
tions, demographic factors and socio-economic status.
Undernutrition
Undernutrition was studied using the anthropomet-
ric data for children under five. A Stata program file 
ZSCORE06 developed by Jef Leroy (Boston College 
Department of Economics) was used to calculate anthro-
pometric z-scores using the 2006 WHO Child Growth 
Standards [32].
Anaemia
Anaemia was classified as mild, moderate or severe based 
on the concentrations of haemoglobin (Hb) as follows; 
(a) mild anaemia: for non-pregnant women, Hb 10.0–
11.9 g/dl; for pregnant women and children under 5, Hb 
10.0–10.9 g/dl; for men: Hb 10.0–12.9 g/dl; (b) moderate 
anaemia: Hb 7.0–9.9 g/dl; c) severe anaemia: Hb <7.0 g/
dl [33].
Serological studies
Optical density (OD) values were analysed in Microsoft 
Excel using a macro file provided by C. Drakeley, Lon-
don School of Hygiene and Tropical Medicine (LSHTM). 
Normalized OD values were used for data analysis using 
a Stata procedure provided by C. Drakeley (LSHTM). A 
cut-off value of 0.177 was used to determine seropositive 
samples. Age seroprevelance curves were generated using 
methods described by Corran et  al. [34]. Data for chil-
dren below 2 years was excluded to avoid potential bias 
caused by maternal antibodies [35].
Under‑5 mortality rates
A variant of the Brass indirect method [36] was used to 
calculate under-five mortality rate (U5MR) using the 
summary birth history dataset provided by women of 
child-bearing age which included age of mother, total 
number of live births and total number of deaths [37]. 
Mortality rates were not calculated for the 3 years period 
before the survey date (2009–2012), namely data related 
to women aged 15–19, because of the selection effect 
where women from lower socioeconomic classes tend 
to start childbearing early and their children face above 
average mortality risks [38]; and because random errors 
are larger for estimates based on the reports of young 
women, since they have fewer children ever born.
Entomological data
Various entomological parameters were estimated 
including species compositions, and indoor resting and 
biting habits. Human biting rates (i.e., the number of 
bites per person per night) were calculated taking into 
account the number of collectors working simultane-
ously, the number of collection nights, and the assumed 
night-time behaviour of the local human populations. It 
was assumed that an average villager in each of the sites 
spends 1  h on average outdoors between 18:00  h and 
22:00 h, and all villagers are indoors after 22:00 h.
Results
A total of 1521 households with complete records were 
included in the analysis of this first survey from the 
four sites in Ethiopia (average 540 per site) and Uganda 
(average 221 per site). Household response rates were 
94.6 and 94.4 % in Ethiopia and Uganda, respectively. In 
total, 8079 people were registered. Nearly all the regis-
tered household members were usual residents, ranging 
from 97.2 % in Aduku (Apac district, Uganda) to 100 % 
in Guba (Halaba Special district, Ethiopia). Females con-
stituted 51.6–53.2 % of the populations in the study sites.
Blood samples for microscopy and serology and body 
temperature measurements were obtained for 66  % of 
registered household members for whom subject cards 
were issued (the rest did not visit the testing site or did 
not provide consent). Blood samples for haemoglobin 
measurements were obtained from 62  % of registered 
subjects (some tests were missed due to shortage of 
equipment).
Malaria prevalence
Prevalence of malaria infection varied between the four 
sites, ranging from 1.4  % in Guba to 9.9  % in Butemba 
(Fig.  1). The predominant species in Ethiopia was Plas-
modium vivax which accounted for 52–67 % of all infec-
tions. In Uganda, P. falciparum accounted for 95–100 %. 
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Malaria prevalence varied among age groups in most 
sites (Fig.  2). The risk of infection tended to be high in 
older subjects in Aduku. The age group pattern in both 
sites of Ethiopia was typical of low endemicity where all 
age groups are more-or-less equally affected, whereas the 
pattern in Butemba (Uganda) reflected moderate ende-
micity where malaria prevalence rates in older children 
and adults are less than rates in younger children as a 
result of acquisition of partial immunity due to repeated 
infections over time [39]. Aduku exhibited a pattern 
somewhat between low and moderate endemicity. The 
seemingly high prevalence in the under-one age group in 
the Hembecho site was due to a small sample size (one 
infection out of seven infants).
Subjects with fever had higher infection prevalence 
than those without fever in Butemba (p  =  0.016) and 
Guba (p < 0.001). History of fever, however, had no asso-
ciation with malaria infection risk in all sites except in 
Guba where subjects with history of fever were more 
likely to be positive (X2 = 30.86, p < 0.001).
The positive and negative predictive values of RDTs for 
these cases were calculated for each site using the slide 
positivity rates determined by microscopy. The negative 
predictive value (NPV) of RDT for P. falciparum was high 
Fig. 1 Malaria prevalence and composition of Plasmodium species in the study sites, October–November 2012
Fig. 2 Malaria prevalence by age group (all species)
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(≥99 %) in all three sites with sufficient sample sizes for 
this analysis (Aduku, Butemba and Hembecho). The posi-
tive predictive value (PPV) of RDT was low in all three 
sites (≤44  %). RDT results for P. vivax infection exhib-
ited a similar pattern of high NPV (≥98 %) and low PPV 
(≤40 %) for the two sites in Ethiopia.
Anaemia
There was a uniformly high prevalence of mild anae-
mia in all sites, ranging from 53 % in Aduku to 65 % in 
Hembecho. However, substantial variation was observed 
in prevalence of moderate and severe anaemia, ranging 
from 2.4 % in Aduku to 6.0 % in Butemba.
Age‑specific seroprevalence
A total of 1123 samples were analysed for the antigen 
MSP-119, 602 for Aduku and 521 for Butemba. Over-
all seropositivity (i.e., the proportion of individuals with 
a positive antibody response to MSP-119) was higher in 
Butemba (45.7 %) than Aduku (22.9 %), indicating higher 
overall exposure to malaria. The seroconversion rate (λ) 
was higher in Butemba compared to Aduku, indicative of 
a higher transmission intensity (Fig. 3).
Under‑five mortality rates
Summary birth histories of 1503 women were available: 
1041 women in Ethiopia and 462 in Uganda. Of these 
88 % had complete data and were retained in the analy-
sis. In total 3317 live births were reported in Ethiopia and 
1101 in Uganda and the average number of live births 
to women aged 15–49  years was approximately 3.5 and 
2.9 in Ethiopia and Uganda, respectively. As expected, 
the number of live births increased in older age groups. 
Mortality rates among live births were 4.1 % in Ethiopia 
and 6.2 % in Uganda. The trend observed for Ethiopia is 
a reduction of almost 60 % in the U5MR from approxi-
mately 60 deaths per 1000 live births for the years prior 
to 2000 to approximately 23 deaths per 1000 live births 
post-2000 (Fig.  4). A similar reduction was observed in 
Uganda. Pre-2000, the U5MR was approximately 113 per 
1000 live births, whereas post-2000, the rates fluctuated 
between 34 and 67.
Ownership and use of ITNs
ITN coverage varied between countries and sites. Hem-
becho had the highest coverage whereas Guba had the 
lowest (Table  2). Net ownership did not vary with SES. 
Purchasing of nets was evident in Uganda but not in 
Ethiopia. In Uganda, 42/606 (7  %) of the mosquito nets 
were purchased by the households themselves. None of 
these nets were identified as ITNs (15 were not ITNs and 
27 were of unknown type). Thirty-one were bought from 
open market, 10 from shops and 1 from a pharmacy. The 
proportion of nets purchased was not higher in the upper 
(richer) socioeconomic groups.
Access of household members to ITNs was calcu-
lated for each study site. To assess access of nets within 
the household, first the potential number of people who 
could use the available nets was computed assuming one 
net for two people. When the potential number of people 
who could use the available nets exceeded the total num-
ber of people who spent the previous night in the house-
hold, the two figures were assumed to be equal. The sum 
of all potential users in the sample was then divided by 
the total number of people who spent the previous night 
in surveyed households to estimate the access rates or the 
proportion of population with access to an ITN within 
the household.
The ITN use rates among those who have access were 
then estimated for each site. The data show that there 
Fig. 3 Age‑specific seroprevalence for P. falciparum anti‑MSP‑119 antibodies. Dots, continuous lines and broken lines represent data, fitted estimates 
and 95 % confidence intervals, respectively. λ is the seroconversion rate. The 0–2 years age group was omitted because of distortions caused by 
presence of maternal antibody in high endemicity settings [35]
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was variation between and within countries in terms of 
access to nets. Hembecho had the highest access rate 
while Guba had the lowest.
Among people with access to ITNs, use rates were high 
in three of the four sites (ranging from 69 to 76 %), with 
the exception of Guba in Ethiopia, where only a third of 
those with access used a ITN the previous night. There 
was no inequity between the sexes in ITN use for any 
site, except for adults in Aduku, where significantly more 
females used an ITN (OR = 1.6; 95 % CI 1.1–2.2).
Indoor residual spraying coverage
No IRS was carried out in Butemba. The remaining three 
study areas contained households that had been sprayed 
in the last 12  months, with or without concurrent ITN 
use. The coverage of IRS was consistently high across the 
villages within each study site. On average, 84 % of house-
holds in Aduku were sprayed within the last 12 months, 
96 % in Hembecho and 85 % in Guba.
Prevalence of infection by use of preventive measures
Individuals who used an ITN the night before the sur-
vey had significantly lower malaria infection prevalence 
in Aduku (2.3 % versus 5.7 %; p = 0.020). No statistically 
significant difference was observed in the other sites. 
There was no statistically significant difference in malaria 
infection prevalence between houses with open/partially 
open or closed eaves in all sites. However, in Guba (the 
site with the lowest ITN ownership and use rates), houses 
with open eaves had slightly higher risk of infection with 
P. falciparum although this was not statistically signifi-
cant (p = 0.087).
Out of the three sites where IRS was implemented, 
prevalence of infection was significantly lower in indi-
viduals living in sprayed houses compared to those in 
unsprayed houses only in Guba (p = 0.042). Among indi-
viduals who slept in sprayed houses, the prevalence of 
infection was significantly lower in those who used ITNs 
in Aduku (p = 0.026), indicating that ITNs are more pro-
tective in this site than they are in the other sites. No 
such association was observed in the other two sprayed 
sites.
Febrile illness in children and treatment‑seeking behaviour
A higher proportion of children under 10  years of age 
had fever or history of fever in the two Ugandan sites 
compared to the Ethiopian sites (Table  3). In Uganda, 
treatment was sought for more than 90 % of all children 
with fever, whereas in Ethiopia, this ranged between 62 
and 80 %. In Aduku, first treatment was most commonly 
Fig. 4 Under‑5 mortality rate estimated from birth history data in 
Ethiopia and Uganda
Table 2 ITN ownership and use rates
Indicator Uganda Ethiopia
Aduku Butemba Hembecho Guba
% households with at least 1 ITN for 2 people 24.3 30.3 24.1 3.6
% households with at least 1 ITN 77.5 67.8 98.2 55.8
% households with at least 2 ITNs 19.5 42.2 73.3 9.8
Number of ITNs per household 1.1 1.5 1.9 0.7
Number of residents per household 5.0 5.3 5.2 5.2
Number of sleeping places 2.5 2.1 2.1 1.9
Number of persons per sleeping place 2.0 2.5 2.5 2.7
% of ITNs used the previous night 81.8 80.0 78.9 28.6
% of people with access to ITNs 43.0 49.2 67.6 25.0
% of people with access who used  
ITNs the previous night
74.9 69.4 76.1 33.4
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sought from privately owned clinics, pharmacies or drug 
shops, while in Butemba similar proportions were treated 
in the public and private sectors. In both Ethiopian sites, 
first treatment was primarily sought in the public sec-
tor. Village Health Teams (VHTs) in Uganda and Health 
Extension Workers (HEWs) in Ethiopia played impor-
tant roles in providing early diagnosis and treatment of 
uncomplicated malaria within their communities.
Anti-malarials were given to the majority of children 
with fevers in all sites with the exception of Hembecho, 
where only 36  % of children received an anti-malarial. 
ACT use varied across the sites (In Ethiopia, chloroquine 
was used as well as ACT as it was first-line treatment for 
vivax malaria). For approximately half of the children 
that were given an anti-malarial in Uganda, treatment 
was started within 24 h following onset of fever. In Ethio-
pia, only 2–7 % of children who received an anti-malar-
ial started the treatment within 24  h of onset of fever. 
Approximately 52–60  % and 77–92  % of children with 
fever who sought treatment received a malaria diagnostic 
test (either RDT or microscopy) in Uganda and Ethiopia, 
respectively.
Prevention of malaria in pregnancy
Overall, IPTp use was more common in Butemba com-
pared to Aduku (X2 = 15.1, p = 0.004), and 36.9 % of the 
women who gave birth within 2 years preceding the sur-
vey took two doses of IPTp, compared to 20.5 % in Aduku 
(Table  4). The proportion of women that took three or 
more doses was around 7–8 % in both sites (IPTp is not 
implemented in Ethiopia).
Knowledge about malaria
A large majority of respondents in Uganda identified 
mosquito bites as the cause of malaria (93  % in Aduku 
and 77 % in Butemba), whereas in Ethiopia the percent-
ages were relatively lower (65 % in Hembecho and 39 % 
in Guba). In Uganda, 89 and 79  % of respondents had 
heard information about malaria in Aduku and Butemba, 
respectively, whereas messages about malaria were less 
frequently heard in Ethiopia (X2 = 158.6, p < 0.001) (61 % 
in Hembecho and 36  % in Guba). The main sources of 
information in the Uganda sites were radio and health 
workers, while in Ethiopia, community leaders and health 
workers were mentioned most often.
Mosquito density and species composition
In Ethiopia, only 22 A. gambiae s.l. females were col-
lected from both sites, which were probably A. arabien-
sis. In Uganda, a total of 1670 and 315 anopheline females 
were collected using the various trapping techniques in 
the Aduku and Butemba sites, respectively. In Aduku, the 
most common vector species was A. funestus s.l. (53  % 
of the collections), while A. gambiae s.l. made up only 
18  % of the collections. The majority of other anophe-
lines considered as non-vectors belonged to the Anoph-
eles coustani complex. In Aduku, 94 % of the A. gambiae 
s.l. were identified as A. arabiensis and 6 % as A. gambiae 
s.s. (molecular identification of A. funestus s.l. is yet to be 
completed).
In Butemba, A. gambiae s.l. was the dominant spe-
cies (89  % of all collections) and no A. funestus s.l. was 
collected. Molecular analysis showed that 93 % of all A. 
Table 3 Prevalence and treatment of fevers in children (10 years or younger) by study site
Site Aduku Butemba Hembecho Guba
Number of children with fever 35 59 42 76
% children with fever in last 48 h 10.3 15.8 4.4 7.3
% children with fever (or history of fever) for whom treatment was sought 94.3 91.5 61.9 80.3
% febrile children who sought treatment in the public sector among those who sought treatment 33.3 48.0 72.2 91.8
% febrile children given any antimalarial (% ACT use) 77.1 (55.6) 72.9 (79.1) 35.7 (86.7) 73.7 (41.1)
% febrile children treated with antimalarial within 24 h of onset of fever 44.4 53.5 6.7 1.8
% of febrile children for whom treatment was sought from any source who were tested 51.6 60.4 76.9 91.8
% of the tests that were done in public health facilities 62.5 75.0 100.0 96.4
Table 4 IPTp use by women who gave birth in the previous 2 years before the survey, Uganda
IPTp is not part of the national malaria control strategy in Ethiopia
Site n IPTp (%)
None 1 Dose 2 Doses 3 Doses Don’t know
Aduku 39 53.8 10.3 20.5 7.7 7.7
Butemba 84 20.2 25.0 36.9 7.1 10.7
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gambiae s.l. mosquitoes collected in Butemba were A. 
gambiae s.s. while 7 % were A. arabiensis.
Vector biting habits
In Butemba, the only vector species caught by HLC was 
A. gambiae s.l. However, only seven mosquitoes were 
caught indoors which was not sufficient to deduce any 
feeding patterns. In Aduku, the A. gambiae s.l. identi-
fied were 17 A. arabiensis and one A. gambiae s.s. These 
were observed to feed primarily after midnight indoors 
(Fig. 5). The number collected was too few to determine 
any behavioural differences between the sibling species. 
A. funestus s.l. was observed to feed much earlier in the 
evening both indoors and outdoors. This result, however, 
requires confirmation and as the molecular analysis of 
A. funestus s.l. has not been completed to confirm if the 
species under question is an important vector, this result 
should be interpreted with caution. Additionally, A. cous-
tani s.l. showed a similar feeding pattern to A. funestus s.l.
Human biting rates (HBR) for all anopheline species 
combined in Aduku was 7.3 anopheline bites per person 
night (Table  5). Anopheles funestus s.l. was the largest 
contributor to the HBR followed by A. coustani s.l. and A. 
gambiae s.l. In Butemba, the HBR was 0.5 bites per per-
son night. If given equal opportunity (or if human baits 
are present both indoors and outdoors) during 1800–
0000 h, A. gambiae s.l. showed a clear preference for bit-
ing outdoors (75  %) in Aduku. In contrast, A. coustani 
s.l. clearly preferred biting indoors (only 24 % preferred 
biting outdoors), whereas A. funestus s.l. readily fed both 
indoors and outdoors.
Nevertheless, assuming that an average villager spends 
one hour outside prior to 2200  h and is indoors after 
2200  h, the majority of human-vector contact for all 
three species occurred indoors, ranging from 83 % for A. 
funestus s.l. to 93 % for A. gambiae s.l. Assuming that by 
2200  h all residents would go to bed, the proportion of 
contact before this time could be used as a proxy for the 
potential risk of malaria exposure. The largest proportion 
of human-vector contact for A. funestus s.l. (65 %) and A. 
coustani s.l. (76 %) took place before 2200 h. For A. gam-
biae s.l. only 13 % of the human-vector contact occurred 
before 2200  h. As mentioned above the results for A. 
funestus s.l. should be interpreted fully only when species 
data is available.
Kdr‑L1014S genotype frequencies
In Butemba, kdr-L1014S (kdr-east) frequencies were 
94.7 % (n = 113) in A. gambiae s.s.; no susceptible indi-
viduals were observed. The few A. arabiensis analysed 
(n  =  7) were all susceptible. In Aduku, A. gambiae s.s. 
showed a high L1014S frequency of 81 % (n = 13), while 
for A. arabiensis frequency was 3 % (n = 252).
Undernutrition
Undernutrition was an important problem in both coun-
tries. However, a far greater proportion of children under 
five in the Ethiopian sites (29-32  %) were underweight 
compared with the Ugandan sites (6–7 %). The Ethiopia 
sites had the highest percentage of children affected by 
undernutrition. Approximately two-thirds of children in 
the Ethiopian sites were stunted (Fig. 6). Wasting, which 
Fig. 5 Nocturnal biting cycle of Anopheles species in Aduku, Apac District. Collection hours: indoors 1801–0600 h and outdoors 1801–0000 h
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is an indicator of acute undernutrition, was most preva-
lent in the Guba site (16.8 %) and affected a much lower 
proportion of children in the Hembecho site (3.4 %). In 
the Butemba site of Uganda, more than a quarter of chil-
dren under five were stunted (no data was collected on 
stunting and wasting in Aduku). In Butemba, 8.1  % of 
children were affected.
Discussion
A comprehensive survey was carried out in four sites in 
Ethiopia and Uganda to gather baseline data for future 
surveys aimed at monitoring changes in malaria epide-
miology and effectiveness of interventions over time. 
Malaria transmission during October–November 2012 
in all locations was low or moderate including in previ-
ously highly endemic areas although the surveys were 
conducted during months normally considered as falling 
in the peak transmission season.
Malaria prevalence in the Ugandan sites was much 
lower than historically recorded, particularly in the dis-
trict of Apac [40]. However, as the studies are only in 
few sites, they may not reflect national trends. It is likely 
that the combined use of both IRS and LLINs led to the 
observed decline. Apac has been under the IRS pro-
gramme since 2007. As baseline transmission levels vary 
across sites, it is inappropriate to compare the four study 
sites; however, it is worth noting that the highest malaria 
prevalence was observed in the site that was not under 
Table 5 Human biting rate (HBR) for each species in study sites in Uganda
a HBR is expressed as the average number of bites per person per night. It was assumed that an average villager spends 1 h outdoors between 1800 and 2200 h and 
the remainder of the night indoors
b Only collections between 1800 and 0000 h were used for both indoors and outdoors for calculations of the extent of exophagic habit of the vector independent of 
night time habits of humans
Site Details A. gambiae s.l. A. funestus s.l. A. coustani s.l.
Aduku Sample size (indoors + outdoors) 19 84 37
Total HBR per person per nighta 1.15 4.04 2.10
% human‑vector contact occurring indoors 92.7 83.0 92.1
% feeding on humans before 2200 h (indoors + outdoors) 12.7 64.9 76.2
% feeding outdoors if given equal opportunity (exophagy)b 75.0 48.0 24.2
Butemba Sample size (indoors and outdoors) 7 0 0
Total HBR per person per night 0.52 0 0
Fig. 6 Percentage of stunted, wasted and underweight children under five Uganda and Ethiopia. Error bars indicate 95 % confidence intervals. 
Height measurements were not taken at Aduku resulting in absence of stunting and wasting data
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IRS in Uganda. The point prevalence data may not rep-
resent the actual average situation in a site. There is con-
siderable seasonality of transmission in both countries 
as well as inter-annual variations. Especially in Ethiopia, 
the variations are likely to be governed by meteorological 
conditions [41, 42]. It is not always possible to accurately 
determine the peak of the transmission seasons correctly. 
In Ethiopia, prevalence rates were generally comparable 
to rates reported in the 2011 MIS survey [14]. However, 
the MIS survey reported dominance of P. falciparum 
contrary to the finding of the present study the previ-
ous year. The dominance of P. vivax in the present study 
could be due to reduced transmission conditions either 
as the result of transmission factors being relatively less 
favourable for P. falciparum or overall reduction of trans-
mission due to the effects of interventions. In Uganda, 
however, prevalence rates were much lower than rates 
reported in the 2009 MIS survey during the same season 
[19].
Serology data can indicate systematic changes in trans-
mission intensity by looking at the age-seroprevalence 
distribution [35]. Serological data confirm a higher 
level of transmission in Butemba compared to Aduku in 
Uganda. The age group pattern of infection prevalence 
also indicates a relatively high transmission situation in 
Butemba. The model does not fit some of the younger age 
groups well in Aduku, which could reflect transmission 
changes due to the ongoing IRS programme using the 
carbamate insecticide bendiocarb. Similarly, in Butemba, 
the youngest age group shows a lower than expected 
seroprevalence rate, which could be due to the LLIN 
mass distribution campaign in 2010. However, small 
sample sizes in younger age groups could also account 
for these findings, and additional serology data from 
subsequent rounds and additional analyses of samples 
from Ethiopia, as well as use of other antigens, can pro-
vide more robust datasets to analyse the interventions in 
terms of transmission changes.
Entomological results yielded important information 
on the situation of vectors. A. gambiae s.s. dominated in 
Butemba, while in Aduku, A. funestus s.l. and A. arabien-
sis were the main vectors. Prior to the scale up of inter-
ventions, A. funestus s.l. was the main vector in Apac 
[40], suggesting more success of the vector control efforts 
against this vector. Most human-vector contact with A. 
gambiae s.l. occurs indoors in Aduku, Uganda, which 
shows that the use of interventions against indoor-bit-
ing vectors should be considered effective. However, the 
early feeding observed for A. funestus s.l. requires confir-
mation with data from subsequent surveys. A substantial 
number of A. coustani s.l. were collected by human land-
ing catch suggesting attraction to humans. Its status as a 
malaria vector is unknown in Uganda. A study in Zambia 
found a high degree of anthropophily in A. coustani s.l. 
[43] and it was reported to be contributing to transmis-
sion in Kenya [44]. Forthcoming analyses will determine 
infectivity rates of vectors to calculate entomological 
inoculation rates.
Insecticide resistance is increasing in many areas of 
Uganda [45, 46]. High kdr-L1014S frequencies were 
observed in A. gambiae s.s. and low frequencies in A. 
arabiensis, a finding which was in line with another study 
from Eastern Uganda [47]. Further studies will be needed 
to confirm the magnitude and impact of insecticide 
resistance in both countries. No tests were done in Ethio-
pia due to small sample size but widespread resistance to 
DDT and pyrethroids has been reported [16, 48]. Resist-
ance against pyrethroids and DDT has reached a high 
level in both countries, probably due to the substantial 
increase in the distribution and use of LLINs in recent 
years as these insecticides share a similar mode of action 
in terms of knock-down resistance.
Regarding diagnosis and treatment, there are varia-
tions observed in both countries, especially around use 
of services. In Uganda, seeking treatment in the private 
sector was common. These findings are in line with the 
MIS 2009 survey, which observed that treatment was 
sought for 82  % of fevers of children under five treat-
ment and 56 % of children with a fever were taken to the 
private sector [19, 49]. In Ethiopia, a great majority of 
febrile children were taken to public health facilities for 
treatment.
As part of the malariometric survey, febrile subjects 
were tested with RDTs which provided an opportunity to 
compare with subsequent microscopy results. The RDTs 
used had high negative predictive value, but their positive 
predictive value was uniformly low in all sites. This shows 
that negative results with the RDTs for febrile patients 
can be a good indicator of absence of infection but a pos-
itive result may not always be a reliable indicator of pres-
ence of infection. These results may be explained by the 
nature of the RDTs that test for the presence of parasite 
antigens which circulate in the blood for several weeks 
post-infection [50, 51].
Prevention of malaria in pregnancy was one of the 
interventions implemented in Uganda. The survey results 
indicated that IPTp uptake was low in Uganda and needs 
to be strengthened if the current recommendation of at 
least three doses is to be reached [52]. The rather low 
coverage or use levels are in line with findings from the 
DHS survey in 2011 which found that 25  % of women 
reported to have taken at least two doses of IPTp [23]. 
While data for Aduku was similar to the national aver-
age in 2011, in Butemba a higher proportion of women 
reported using IPTp, likely due to activities of various 
projects in this region working to improve its uptake.
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Knowledge of malaria varied among the sites. House-
holds in the Ugandan sites had overall better knowledge 
about malaria compared to the Ethiopian sites. How-
ever, in Butemba, other causes of malaria were frequently 
cited, unlike in Aduku where most respondents correctly 
identified mosquitoes as the only cause of malaria, likely 
because of behavioural change communication (BCC) 
campaigns that accompanied IRS implementation. In 
Guba, knowledge about the cause of malaria needs to be 
improved through appropriate community education. 
In connection with this, the low ITN ownership and use 
rates in Guba and possibly surrounding areas in Ethiopia 
will require close attention by the health services.
Universal coverage is defined differently in the two 
countries: two ITNs per household in Ethiopia and one 
ITN for two people in Uganda. In one of the Ethiopian 
sites (Hembecho), the goal was nearly achieved with 1.9 
ITNs per household whereas ownership in the second 
site (Guba) was the lowest of all sites (0.7 ITNs). The 
cause of the low ownership rate in Guba requires more 
investigation. In Uganda, although the percentages of 
sleeping places that can potentially be covered with ITNs 
available in the households were 44 and 71 % in Aduku 
and Butemba, respectively, the percentages of households 
with one ITN for two people were 24 and 30 %, respec-
tively. The ITN coverage is expected to increase substan-
tially following a recent nationwide campaign in Uganda.
Uniformly high IRS coverage was observed in the 
sprayed sites. In one of the four sites (Aduku), individu-
als who slept under an ITN the night before the survey 
had lower risk of infection than those who did not. This 
could be due to low level of pyrethroid resistance in that 
site [53]. The lack of association in ITN use and malaria 
in the other sites does not necessarily translate to lack of 
effectiveness. It may be partly explained by ‘mass’ effects 
of ITNs or IRS (in the sprayed sites) which could con-
found the result, as people who did not use nets might 
have been ‘protected’ by either all other nets in the vil-
lages or the IRS due to mortality effects on mosquito vec-
tors or a combination of these.
It is not clear whether ITN and IRS have an additive or 
synergistic action when used in combination. The current 
WHO recommendation is that where LLIN coverage is 
high and they remain effective, IRS may have limited util-
ity in reducing malaria morbidity and mortality, unless 
the combined use is for resistance management [54]. In 
Guba where both ITN ownership and use rates were low, 
malaria infection risk was higher in individuals living in 
unsprayed houses than in sprayed ones, indicating the 
potential benefit of the combined use of both interven-
tions in such situations.
One of the main observations in the present sur-
vey was the high level of undernutrition in the study 
sites. Undernutrition during the critical first 1000  days 
of a child’s life could have devastating consequences by 
increasing morbidity and mortality and development of 
the child. Recently, stunting (or low height for age) has 
been chosen as a key indicator to measure global and 
national progress towards reduction of undernutrition 
[55]. Undernutrition is particularly a severe problem in 
the Ethiopia sites where two-thirds of the children were 
classified as stunted. Critical nutrition interventions 
should be strengthened addressing both maternal and 
child undernutrition. These include, among others, pro-
moting optimal breastfeeding practices, micronutrient 
supplementation, reducing incidence of low birth weight 
and prevention of disease.
Conclusion
Low malaria prevalence was observed in some sites that 
previously had high endemicity but there was substan-
tial variation between sites. Intensified vector control 
and effective treatment seem to have played key roles in 
bringing endemicity down over recent years, as reflected 
in the results of serological analyses. Malaria control 
efforts should be sustained to reduce transmission fur-
ther, maintain the gains and prevent resurgence. Control 
strategies should be adapted to the changing patterns 
and heterogeneity of transmission which may require 
a thorough epidemiological stratification and selective 
targeting of interventions. A tendency of early biting in 
A. funestus s.l. in Aduku requires further investigation. 
The impact of pyrethroid resistance in A. gambiae s.s. in 
Uganda on effectiveness of LLINs should be studied fur-
ther. Pre-emptive rotation of insecticides should be con-
sidered by IRS programmes. Non-pyrethroid IRS may be 
considered when feasible and where other measures have 
inadequate impact, or in areas where there are major 
obstacles to achieving high ownership and use of LLINs. 
Robust continuous distribution systems are needed to 
replace LLINs and maintain high coverage. Whether 
low LLIN coverage in Guba is indicating a similar prob-
lem elsewhere should be investigated and more efforts 
are needed to create a culture of net use. Health services 
should create conditions to make LLINs available in the 
commercial market at affordable prices and educate com-
munities on the benefits of LLINs over untreated nets.
The findings will serve as a baseline against which 
results of future surveys or other studies could be com-
pared. Although results from a small number of study 
sites may not be nationally representative, the approach 
provides more comprehensive information on a range of 
potential determinants of malaria rates than more geo-
graphically extensive surveys and surveillance, and they 
will provide a basis for and may prompt further inves-
tigations of some of the observations. It is necessary to 
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continue monitoring the epidemiological changes and 
more studies through in-depth analysis and modelling 
will reveal the impact of the various interventions on 
malaria transmission.
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